Trial intelligence / Profile preview

Transdermal Estrogen for Bone Loss in Anorexia Nervosa

NCT02475265Phase 2Completed

Sponsor
Massachusetts General Hospital
Start
Jul 2015
Primary completion
Jun 2018
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in osteopenia, osteoporosis, sponsored by Massachusetts General Hospital. Started Jul 2015; status: completed.

02

Drugs

estradiol
03

Conditions

osteopeniaosteoporosis

Beyond the preview

Go deeper on NCT02475265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02475265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call